Climb Bio, Inc. (CLYM) has 4 open-market insider trades by 3 insiders since 2025. The most active filer is Stephen Basil Thomas, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Kolchinsky | Dir10% Owner | — | 1 | $1.5M | 2025-12-12 |
| Stephen Basil Thomas | Dir | — | 2 | $879K | 2026-09-15 |
| RA Capital Healthcare Fund LP | Dir10% | — | 1 | $25K | 2026-01-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Stephen Basil Thomas | Director | Sell | $1.4M | 2026-09-15 |
| Aoife Brennan | CEO & President | Sell | $407K | 2026-06-29 |
| Stephen Basil Thomas | Director | Sell | $350K | 2026-02-25 |
| Stephen Basil Thomas | Director | Sell | $529K | 2026-02-12 |
| RA Capital Healthcare Fund LP | Director & 10% | Buy | $25K | 2026-01-05 |
| Peter Kolchinsky | Director & 10% Owner | Buy | $1.5M |
Companies that share insiders with CLYM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-12-11 |
| Aoife Brennan | President | Sell | $25K | 2025-06-30 |
| Emily Pimblett | SVP & Finance & CAO | Sell | $2K | 2025-06-20 |
| Emily Pimblett | SVP & Finance & CAO | Sell | $2K | 2025-03-20 |
| Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sell | $2K | 2024-12-19 |